Thus, the down-regulated expression of ICOS and ICOSL on hBEC by EPs 7630 may have two beneficial effects in chronic inflammatory lung diseases: (i) it reduces the ability of rhinovirus to bind to the host epithelial cell surface and prevent infection, and (ii) it reduces immune cell mediated inflammation. This evidence concerns the gene ICOS and infection.